TickerFacts.

A business in context

STRO research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-09-07 · 8010 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001193125-26-345748

  2. 8-K · Current report

    Report date 2026-08-12 · 0001193125-26-345733 · Items 2.02,7.01,9.01

  3. 4 · Ownership change

    Report date 2026-06-05 · 0001891841-26-000002

  4. 4 · Ownership change

    Report date 2026-06-05 · 0001601264-26-000006

  5. 4 · Ownership change

    Report date 2026-06-05 · 0001587487-26-000002

  6. 4 · Ownership change

    Report date 2026-06-05 · 0001554591-26-000002

  7. 4 · Ownership change

    Report date 2026-06-05 · 0001536193-26-000002

  8. 4 · Ownership change

    Report date 2026-06-05 · 0001294939-26-000002

  9. 4 · Ownership change

    Report date 2026-06-05 · 0001236537-26-000002

  10. 4 · Ownership change

    Report date 2026-06-05 · 0001217412-26-000002

  11. 8-K · Current report

    Report date 2026-06-05 · 0001193125-26-261658 · Items 5.07

  12. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001193125-26-224170

  13. 8-K · Current report

    Report date 2026-05-14 · 0001193125-26-224065 · Items 2.02,9.01

  14. DEF 14A · Proxy statement

    Report date 2026-06-05 · 0001193125-26-170354

  15. 10-K · Annual report

    Report date 2025-12-31 · 0001193125-26-119873

  16. 8-K · Current report

    Report date 2026-03-23 · 0001193125-26-119844 · Items 1.02,2.02,9.01

  17. 8-K · Current report

    Report date 2026-02-09 · 0001193125-26-044934 · Items 1.01,7.01,9.01

  18. 8-K · Current report

    Report date 2025-12-17 · 0001193125-25-322859 · Items 8.01

  19. 8-K · Current report

    Report date 2025-12-01 · 0001193125-25-306786 · Items 3.03,5.03,8.01,9.01

  20. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001193125-25-270036

  21. 8-K · Current report

    Report date 2025-11-06 · 0001193125-25-269833 · Items 2.02,9.01

  22. 8-K · Current report

    Report date 2025-09-29 · 0001193125-25-223434 · Items 2.05,9.01

  23. 10-Q · Quarterly report

    Report date 2025-06-30 · 0000950170-25-105219

  24. 8-K · Current report

    Report date 2025-08-07 · 0000950170-25-105159 · Items 2.02,9.01

  25. 8-K · Current report

    Report date 2025-06-20 · 0000950170-25-089978 · Items 3.01

  26. 8-K · Current report

    Report date 2025-06-06 · 0001193125-25-138481 · Items 5.07

  27. 8-K · Current report

    Report date 2025-06-02 · 0001193125-25-133268 · Items 5.02

  28. 10-Q · Quarterly report

    Report date 2025-03-31 · 0000950170-25-067072

  29. 8-K · Current report

    Report date 2025-05-08 · 0000950170-25-067061 · Items 2.02,9.01

  30. DEF 14A · Proxy statement

    Report date 2025-06-06 · 0000950170-25-058774

  31. 8-K · Current report

    Report date 2025-04-10 · 0000950170-25-053733 · Items 5.02

  32. 10-K · Annual report

    Report date 2024-12-31 · 0000950170-25-038884

  33. 8-K · Current report

    Report date 2025-03-13 · 0000950170-25-038879 · Items 2.02,2.05,5.02,9.01

  34. 8-K · Current report

    Report date 2024-12-10 · 0000950170-24-134765 · Items 8.01

  35. SC 13G/A · Ownership disclosure

    0000921895-24-002724

  36. SC 13G/A · Ownership disclosure

    0000902664-24-006662

  37. SC 13G/A · Ownership disclosure

    0001104659-24-117750

  38. 10-Q · Quarterly report

    Report date 2024-09-30 · 0000950170-24-126407

  39. 8-K · Current report

    Report date 2024-11-13 · 0000950170-24-126382 · Items 2.02,9.01

  40. SC 13G/A · Ownership disclosure

    0000932471-24-001222

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-09-07 · 2026 Q2: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 0 transaction rows0SGrant / award: 8 transaction rows8AExercise / conversion: 2 transaction rows2MTax / exercise payment: 0 transaction rows0FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

10 matching transaction rows.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-06-05
2026-06-09
Hunter HeidiA · Grant / award
Acquired
Stock Option (right to buy)
Derivative security
10000.00.0
2026-06-05
2026-06-09
Dybbs MichaelA · Grant / award
Acquired
Stock Option (right to buy)
Derivative security
10000.00.0
2026-06-05
2026-06-09
Wigginton Jon MarcA · Grant / award
Acquired
Stock Option (right to buy)
Derivative security
10000.00.0
2026-06-05
2026-06-09
Jagpal SukhiA · Grant / award
Acquired
Stock Option (right to buy)
Derivative security
10000.00.0
2026-06-05
2026-06-09
Lobacki Joseph MA · Grant / award
Acquired
Stock Option (right to buy)
Derivative security
10000.00.0
2026-06-05
2026-06-09
Petree Daniel HA · Grant / award
Acquired
Stock Option (right to buy)
Derivative security
10000.00.0
2026-06-05
2026-06-09
MATSUI CONNIEA · Grant / award
Acquired
Stock Option (right to buy)
Derivative security
10000.00.0
2026-06-05
2026-06-09
PANEK JAMES PA · Grant / award
Acquired
Stock Option (right to buy)
Derivative security
10000.00.0
2026-06-02
2026-06-02
Chow Gregory K.M · Exercise / conversion
Acquired
Common Stock2500.00.0
2026-06-02
2026-06-02
Chow Gregory K.M · Exercise / conversion
Disposed
Restricted Stock Units (RSUs)
Derivative security
2500.00.0

Identity & relationships

Wikidata structured data · retrieved 2026-09-07 · 1611 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001382101SUTRO BIOPHARMA, INC.

No parent relationship is available in this import; this is not proof of independence.

Legal Entity Identifier
5493005U6P15VD25P851
GLEIF legal name
Sutro Biopharma, Inc.
Entity / LEI registration status
ACTIVE / LAPSED
Reference data updated
2026-06-17T18:50:32Z

direct-parent: no parent LEI supplied

ultimate-parent: no parent LEI supplied

GLEIF legal entity reference data · retrieved 2026-09-07 · 1177 checked identities; 0 unavailable records

Search names and former names

View Wikidata identity and references ↗

  • Sutro Biopharma · alias · wikidata
  • SUTRO BIOPHARMA INC · former SEC name · 2009-03-11 to 2018-11-08
  • Fundamental Applied Biology Inc · former SEC name · 2006-11-08 to 2007-10-24
Explore headquarters map ↗

Revenue in constant purchasing power

USD revenue expressed in 2026-07 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

Year endedReported USD revenueCPI-adjusted USD revenue
2024-12-31$62.04M$66.04M
2023-12-31$153.73M$168.46M
2022-12-31$67.77M$77.31M
2021-12-31$61.88M$76.24M
2020-12-31$42.72M$55.12M
2019-12-31$42.74M$55.81M
2018-12-31$38.42M$51.09M
2017-12-31$51.74M$70.48M

Bureau of Labor Statistics · retrieved 2026-09-07 · 9 selected series; gaps remain missing

Explore the CPI history ↗